2014 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2016.
- Report compiled based on cases received by WADA before 21 February 2016

The World Anti-Doping Agency (WADA) has published its second annual Anti-Doping Rule Violations (ADRVs) Report, which represents the most comprehensive set of global doping statistics in sport for 2014.

The Report highlights that there was a total of 1,693 ADRVs recorded in 2014, involving individuals from 109 nationalities and across 83 sports. 1,462 of the ADRVs were derived from adverse analytical findings (AAFs); these 1,462 ADRVs represented 64% of the total 2,287 AAFs that were reported by WADA-accredited laboratories. The remaining 231 non-analytical ADRVs were issued as a result of evidence-based intelligence; of which, 185 were committed by athletes and 46 by athlete support personnel.

It is important to note that the 2014 ADRVs Report is based on violations that were committed and adjudicated pursuant to the 2009 World Anti-Doping Code (Code). Statistics related to violations committed and adjudicated pursuant to the 2015 Code will be released in 2017.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2014 AAFs by Sport Category
Section 2: Outcomes of 2014 AAFs by Testing Authority Category
Section 3: Report of 2014 Non-Analytical ADRVs
Section 4: Report of 2014 Total Analytical and Non-Analytical ADRVs

2014 Anti-Doping Testing Figures Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2015

Contents:

- Laboratory Report – pp. 2-16 (15 pages)
- Sport Report – pp. 18-65 (47 pages)
- Testing Authority Report – pp. 66-172 (106 pages)
- ABP Report-Blood Analysis – pp. 173-202 (29 pages)

2015 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2017.
- Report compiled based on cases received by WADA before 31 January 2017

The World Anti-Doping Agency (WADA) has published its third annual Anti-Doping Rule Violations (ADRVs) Report, which is the first set of Anti-Doping Rule Violation statistics under the revised World Anti-Doping Code (Code). An ADRV is a doping offence committed by an athlete or athlete support person, which results in certain consequences or sanctions.

The Report illustrates doping offences committed in global sport during 2015. It highlights that there was a total of 1,929 ADRVs recorded in 2015, involving individuals from 122 nationalities and across 85 sports. 1,649 of the ADRVs were derived from adverse analytical findings (AAFs), commonly known as ‘positive’ results; these 1,649 ADRVs represented 65% of the total 2,522 AAFs that were reported by WADA-accredited laboratories. The remaining 280 non-analytical ADRVs were issued as a result of evidence-based intelligence; of which, 252 were committed by athletes and 28 by athlete support personnel. This represents an increase in non-analytical ADRVs, and is in line with the anti-doping movement’s increased focus on investigations, intelligence-gathering and whistleblowing.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2015 AAFs by Sport Category
Section 2: Outcomes of 2015 AAFs by Testing Authority Category
Section 3: Report of 2015 Non-Analytical ADRVs
Section 4: Report of 2015 Total Analytical and Non-Analytical ADRVs

2015 Anti-Doping Testing Figures Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2016

Contents:

- Laboratory Report – pp. 2-22 (21 pages)
- Sport Report – pp. 23-116 (93 pages)
- Testing Authority Report – pp. 117-239 (122 pages)
- ABP Report-Blood Analysis – pp. 240-273 (33 pages)

2016 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018.
- Report compiled based on cases received by WADA before 31 December 2017

This is the fourth year that WADA publishes the ADRVs Report. The Report illustrates doping offences committed under the World Anti-Doping Code in 2016.

The Report includes the decisions of all adverse analytical findings (AAFs) for which the samples were collected by anti-doping organizations (ADOs) in 2016 and the results are reported in ADAMS as well as non-analytical anti-doping rule violations for decisions rendered in 2016. Discrepancy from ADOs’ published statistics may occur due to different reporting criteria.

The ADRVs Report is broken down as follows:

• An Introduction and an Executive Summary, which provide an overview of the Report and highlight the key observations of the 2016 ADRVs Report.
• Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected from athletes in- and out-of-competition in 2016. They are presented by sport, discipline (Section 1) and testing authority (Section 2).
• Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by athlete support personnel (presented by nationality).
• Section 4 indicates the total number of ADRVs from athletes in 2016, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. The data is presented by sport and nationality. The information is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete gender.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2016 AAFs by Sport Category
Section 2: Outcomes of 2016 AAFs by Testing Authority Category
Section 3: Report of 2016 Non-Analytical ADRVs
Section 4: Report of 20165 Total Analytical and Non-Analytical ADRVs

2016 Anti-Doping Testing Figures Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2017

Contents:

- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-150 (113 pages)
- Testing Authority Report - pp. 151-287 (136 pages)
- ABP Report-Blood Analysis - pp. 288-323 (35 pages)

2017 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019.
- Report compiled based on cases received by WADA before 31 May 2019

This is the fifth year that WADA publishes the ADRVs Report. The Report illustrates doping offencescommitted under the World Anti-Doping Code (Code) in 2017.

The Report includes the decisions received by WADA before 31 May 2019 of all Adverse AnalyticalFindings (AAFs) for which the samples were collected by Anti-Doping Organizations (ADOs) in 2017and reported in ADAMS. This also includes Non-Analytical Anti-Doping rule violations for decisionsrendered in 2017. Discrepancy from ADOs’ published statistics may occur due to different reportingcriteria.

The ADRVs Report is divided as follows:

1.) An Introduction and an Executive Summary which provide an overview and highlight the key observations of the 2017 ADRVs Report.
2.) Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected from athletes in- and out-of-competition in 2017. They are presented by sport, discipline (Section 1) and testing authority (Section 2).

3.) Section 3 includes ADRVs that resulted from Non-Analytical findings committed by Athletes (presented by sport and nationality) and by Athlete Support Personnel (presented by nationality).

4.) Section 4 indicates the total number of ADRVs from Athletes in 2017, which includes AAFs that resulted in an ADRV and all Non-Analytical ADRVs. The data is presented by sport andnationality.
The information is further divided into:
- Sample type (urine or blood),
- Type of test (in- or out-of-competition), and;
- Athlete gender.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2017 AAFs by Sport Category
Section 2: Outcomes of 2017 AAFs by Testing Authority Category
Section 3: Report of 2017 Non-Analytical ADRVs
Section 4: Report of 2017 Total Analytical and Non-Analytical ADRVs

2017 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018

Contents:

- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-158 (121 pages)
- Testing Authority Report - pp. 159-298 (139 pages)
- ABP Report-Blood Analysis - pp. 299-336 (37 pages)

2018 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020. - Report compiled based on decisions received by WADA before 2 March 2020

• The Report highlights 1,923 confirmed Anti-Doping Rule Violations (ADRVs) in 2018, involving individuals from 117 nationalities and across 92 sports
• 1,640 ADRVs came from Adverse Analytical Findings and 283 from non-analytical, evidence-based intelligence

The World Anti-Doping Agency (WADA) has publishes its sixth annual Anti-Doping Rule Violations (ADRVs) Report, which is the official set of such figures under the World Anti-Doping Code. As usual, the Report is available in a PDF version as well as a dynamic, Excel version that illustrates the ADRV results in an interactive fashion.

The Report illustrates doping offences committed in global sport during 2018. It highlights that there were a total of 1,923 ADRVs recorded in that year. This represents a 6.5% increase relative to the 2017 figure of 1,804, which in turn was 13% more than 2016.

1,640 of the ADRVs came out of Adverse Analytical Findings (AAFs), commonly known as ‘positive’ results. The remainder were derived from investigations and evidence-based intelligence into 267 violations committed by athletes and 16 by athlete support personnel (ASP).

The report contains all ADRV decisions reported to WADA by Anti-Doping Organizations (ADOs). These decisions include those from AAFs reported in samples collected by ADOs in 2018 as well as from non-analytical ADRV decisions rendered in 2018.

As with previous years, the beginning of the report comprises an introduction and an executive summary highlighting key data. The first and second sections present the Results Management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected in 2018 from athletes in- and out-of-competition. They are presented by sport, discipline (Section 1) and testing authority (Section 2).

Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by ASP (presented by nationality).

Section 4 indicates the total number of ADRVs in 2018, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. It presents the data by sport and nationality. It is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete gender.

2018 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019

Contents:

- Executive Summary - pp. 2-6 (5 pages)
- Laboratory Report -– pp. 7-34 (28 pages)
- Sport Report - pp. 35-159 (125 pages)
- Testing Authority Report - pp. 160-304 (145 pages)
- ABP Report-Blood Analysis - pp. 305-343 (39 pages)